Xu Qingzhou, Sun Xueying, Yang Weiyuan, Bai Yanli, Tan Xiaoyan
Hebenmu Medical Aesthetic Outpatient, Hangzhou, 310000, People's Republic of China.
Hangzhou Plastic Surgery Hospital, Hangzhou, 310000, People's Republic of China.
Aesthetic Plast Surg. 2024 Dec;48(23):5115-5135. doi: 10.1007/s00266-024-04098-8. Epub 2024 Jun 20.
With the increasing global clinical application of regenerative injection materials, there is a growing recognition of the crucial role played by poly-L-lactic acid (PLLA). The aim of this study is to conduct a systematic review on the therapeutic efficacy and safety of PLLA in clinical applications for facial treatments.
We conducted a search of the PubMed, EMBASE, Web of Science, and Wanfang databases, followed by screening of the retrieved articles based on predefined inclusion and exclusion criteria. We then performed an analysis on the final set of included articles that met our inclusion criteria. Within these included articles, quality assessment for randomized controlled trials (RCTs) was carried out using the Jadad scale, while non-randomized controlled trials (non-RCTs) were evaluated using the MINORS scale.
Our search of above database, using the relevant search terms, yielded a total of 1300 PLLA-related articles. After applying the inclusion and exclusion criteria, 1280 articles were excluded. Only 20 articles, 16 in English and 4 in Chinese, were included in our final analysis, among them 16 NRCTs and 4 RCTs. According to the different clinical evaluation standards, the treatment of PLLA has achieved good outcomes. Most PLLA injection-related adverse events are mild and self-limited, without any additional treatment requirement.
PLLA is a reasonably safe and effective facial injection material that can be applied in different facial injection areas and depth using various reconstitute and injection methods.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
随着再生注射材料在全球临床应用的不断增加,聚左旋乳酸(PLLA)所起的关键作用也日益得到认可。本研究旨在对PLLA在面部治疗临床应用中的治疗效果和安全性进行系统评价。
我们检索了PubMed、EMBASE、科学网和万方数据库,然后根据预先设定的纳入和排除标准对检索到的文章进行筛选。接着,我们对符合纳入标准的最终文章集进行分析。在这些纳入的文章中,使用Jadad量表对随机对照试验(RCT)进行质量评估,而使用MINORS量表对非随机对照试验(非RCT)进行评估。
我们使用相关检索词在上述数据库中进行检索,共获得1300篇与PLLA相关的文章。应用纳入和排除标准后,排除了1280篇文章。最终分析仅纳入20篇文章,其中16篇为英文,4篇为中文,其中16篇为非随机对照试验,4篇为随机对照试验。根据不同的临床评价标准,PLLA治疗取得了良好的效果。大多数与PLLA注射相关的不良事件轻微且具有自限性,无需任何额外治疗。
PLLA是一种相当安全有效的面部注射材料,可使用各种复溶和注射方法应用于不同的面部注射区域和深度。
证据水平I:本刊要求作者为每篇文章指定一个证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南www.springer.com/00266 。